Search Results

You are looking at 11 - 20 of 906 items for :

  • "radiation therapy" x
  • Refine by Access: All x
Clear All
Full access

Role of Radiation Therapy in Retroperitoneal Sarcoma

Kilian E. Salerno and Elizabeth H. Baldini

updated consensus approach from the Transatlantic Australasian RPS Working Group . Ann Surg Oncol 2021 ; 28 : 7873 – 7888 . 10.1245/s10434-021-09654-z 6. Salerno KE , Alektiar KM , Baldini EH , Radiation therapy for treatment of

Full access

Combined Chemotherapy and Radiation Therapy for Cervical Cancer

David H. Moore

. CA Cancer J Clin 2003 ; 53 : 5 – 26 . 2 Fu KK . Biological basis for the interaction of chemotherapeutic agents and radiation therapy . Cancer 1985 ; 55 : 2123 – 2130 . 3 Sinclair WK . Hydroxyurea: Effects on Chinese

Full access

Contemporary Radiation Therapy in Combined Modality Therapy for Hodgkin Lymphoma

Amol K. Narang and Stephanie A. Terezakis

, radiation therapy (RT) alone was the backbone of management for Hodgkin lymphoma (HL). Despite high tumor control rates with RT alone, large treatment fields were required that included uninvolved lymph nodes at risk. As a result, patients incurred late

Full access

Radiation Therapy Advances for Treatment of Anal Cancer

Joseph M. Pepek, Christopher G. Willett, and Brian G. Czito

Techniques for the treatment of anal cancer have developed in parallel with technologic advances in radiation therapy (RT). Combined chemotherapy and RT has replaced radical surgical resection as the cornerstone of treatment for anal malignancies

Full access

Radiation Therapy in Operable and Locally Advanced Pancreatic Cancer

Andrew H. Ko and Christopher H. Crane

W hen considering the role of radiation therapy in operable and locally advanced pancreatic cancer, it becomes necessary to examine the patterns of locoregional versus systemic failure in these disease settings. For example, data from single

Full access

Combined Androgen Blockade in Localized Prostate Cancer Treated With Definitive Radiation Therapy

Lucas K. Vitzthum, Chris Straka, Reith R. Sarkar, Rana McKay, J. Michael Randall, Ajay Sandhu, James D. Murphy, and Brent S. Rose

Background Multiple randomized controlled trials have shown that androgen deprivation therapy (ADT) improves outcomes for men with intermediate- or high-risk prostate cancer (PCa) treated with radiation therapy (RT). 1 – 4 These trials used

Full access

Evolution of Radiation Therapy Within the German Hodgkin Study Group Trials

Hans Theodor Eich, Jan Kriz, and Rolf-Peter Müller

analyses, never as prospective randomized trials, and mostly for radiation therapy only. No substantial data exist for the combined modality treatment of radiotherapy and chemotherapy. Therefore, the HD10 trial was initiated to answer 2 questions for early

Full access

Salvage or Adjuvant Radiation Therapy: Counseling Patients on the Benefits

Matthew E. Nielsen, Bruce J. Trock, and Patrick C. Walsh

. 17. Stephenson AJ Scardino PT Kattan MW . Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy . J Clin Oncol 2007 ; 25 : 2035 – 2041 . Erratum in: J Clin Oncol 2007;25:4153 . 18

Full access

NCCN Guidelines Update: Evolving Radiation Therapy Recommendations for Breast Cancer

Kilian E. Salerno

commercial interests with the manufacturers of any products discussed in this article or their competitors. References 1. Whelan TJ Pignol JP Levine MN . Long-term results of hypofractionated radiation therapy for breast cancer . N Engl J

Full access

Impact of Immunotherapy on the Survival of Patients With Cancer and Brain Metastases

Saber Amin, Michael Baine, Jane Meza, and Chi Lin

, with a median survival time of 4 to 16 months, depending on the primary site. 4 – 6 Current treatment modalities available for the treatment of BMs are surgery, whole-brain radiation therapy (RT), and stereotactic radiosurgery (SRS). 7 , 8 The most